Consensus Organigram Global Inc.

Stocks

OGI

CA68617J1003

Healthcare Facilities & Services

Market Closed - Toronto S.E. 08:00:00 07/11/26 am AEDT			5-day change	1st Jan Change
1.250 ^CAD	-2.34%		-5.30%	-45.89%

04/11	Organigram Global to Acquire Aurora Cannabis for CA$7.80 per Common Share	MT
04/11	Organigram to Acquire Aurora Cannabis for $5.58 a Share	MT

Evolution of the Average Target: Organigram Global Inc.

Evolution of the Target Price: Organigram Global Inc.

Changes in Analyst Recommendations: Organigram Global Inc.

05ee7e9af8.KUqAdujiikdXpQEgGPsd3g8UuweqSFOyJ2MWYT07gFE.Sn-5J92X0wAhwld5YshLqVs54XGfFzzechphJlVL8TJ_Itggv67OICD1bg~a051a3625e987c21fbac5f88bf8aea66

Analysts' recommendations: Organigram Global Inc.

23/03	Organigram Says Proxy Firm ISS Recommends Approval of Sanity Group Acquisition	MT
23/03	Organigram Brief: Announced Independent Proxy Advisory Firm ISS Recommends OGI Shareholders Vote FOR Acquisition of Sanity Group GmbH	MT
21/10/25	Organigram Brief: Announcing Update to CEO Succession Plan	MT
16/04/24	Alliance Global Upgrades OrganiGram Holdings to Buy From Neutral	MT
18/07/23	Organigram Holdings Maintained at Buy at Stifel GMP Following Q2 Results; Price Target Raised to C$4.00	MT
14/04/23	Organigram Holdings Maintained at Buy at Stifel GMP After Mixed Fiscal Q2 Results; Price Target Lowered to C$1.25	MT
14/01/23	Organigram Holdings Raised to Buy at Stifel GMP Following Improved FQ1 Results; Price Target Kept at C$1.50	MT
30/11/22	Organigram Holdings Maintained at Hold at Stifel GMP Following FQ4 Results; Price Target Kept at C$1.50	MT
16/07/22	Organigram Holdings Hold Rating Maintained by Stifel GMP Following Fiscal Third-Quarter Results	MT
14/04/22	Organigram Holdings Shares Rise 4%, Upgraded to Outperform at ATB Capital	MT
13/01/22	Canaccord Genuity Upgrades OrganiGram Holdings to Speculative Buy from Hold, Adjusts Price Target to CA$3.25 from CA$3	MT
13/01/22	Organigram Holdings Price Target Raised to $3 at ATB Capital	MT
16/07/21	OrganiGram : Stifel Nicolaus Adjusts OrganiGram Holdings PT to C$3.75 From C$4, Maintains Hold Rating	MT
15/07/21	OrganiGram : CIBC Adjusts OrganiGram Holdings PT to C$4 From C$3.75, Maintains Neutral Rating	MT
12/06/21	OrganiGram : CIBC Adjusts OrganiGram Holdings PT to C$3.75 From C$3.25, Maintains Neutral Rating	MT
12/05/21	OrganiGram : CIBC Upgrades OrganiGram Holdings to Neutral from Underperform, Keeps C$3.25 Price Target	MT
16/04/21	OrganiGram : Stifel Nicolaus Adjusts OrganiGram Holdings PT to C$4 From C$6, Maintains Hold Rating	MT
15/04/21	OrganiGram : Raymond James Adjusts OrganiGram Holdings PT to C$5 From C$6, Maintains Outperform Rating	MT
14/04/21	Organigram : Declines 7% As CIBC Downgrades Stock After Weak Q2 Results	MT
14/04/21	OrganiGram : CIBC Downgrades OrganiGram Holdings to Underperform from Neutral, Adjusts PT to C$3.25 from C$5	MT
09/04/21	OrganiGram : BMO Capital Upgrades OrganiGram Holdings to Market Perform from Underperform, Sets C$4 Price Target	MT
13/03/21	OrganiGram : Raymond James Adjusts OrganiGram Holdings PT to C$6 From C$3, Maintains Outperform Rating	MT
12/03/21	OrganiGram : Alliance Global Partners Adjusts OrganiGram Holdings PT to C$4 From C$2.25, Maintains Neutral Rating	MT
11/03/21	OrganiGram : BMO Capital Downgrades OrganiGram Holdings to Underperform From Market Perform	MT
14/01/21	OrganiGram : Raymond James Upgrades OrganiGram Holdings to Outperform From Market Perform; Price Target is C$3	MT

More recommendations

Medical Farming

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	ORGANIGRAM GLOBAL INC.					+133.6%
	CVS HEALTH CORPORATION					+35.67%
	HCA HEALTHCARE, INC.					-3.58%
	NATERA, INC.					+34.03%
	FRESENIUS SE & CO. KGAA					+7.42%
	LABCORP HOLDINGS INC.					+5.64%
	QUEST DIAGNOSTICS INCORPORATED					+0.64%
	TENET HEALTHCARE CORPORATION					+7.82%
	DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY					+23.1%
	IHH HEALTHCARE					+34.15%
	Average					+27.85%
	Weighted average by Cap.					+16.37%